We are currently discussing possible new vaccine candidates for therapy of herpes simplex, and planning new clinical trials.Among these is a live, replication-defective HSV-2 vaccine that we showed this past year to be effective in the immunotherapy of genital herpes in the gunea pig model.
Marques, A R; Straus, S E; Fahle, G et al. (2001) Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol 7:82-3 |
Marques, A R; Straus, S E (2000) Herpes simplex type 2 infections--an update. Adv Intern Med 45:175-208 |
Marques, A R; Straus, S E (2000) Herpes simplex type 2 infections--an update. Dis Mon 46:325-59 |